Sitagliptin Products | Cleanchem - A DPP-4 inhibitor used to treat type 2 diabetes by enhancing incretin hormone activity. It promotes insulin secretion and suppresses glucagon release in response to meals. Often used in combination therapy.

N-Nitroso Sitagliptin Impurity 1

Cat. No: CL-STG-NO-01

CAS No: 2892260-32-9

Mol. F: C6H6F3N5O

Mol. Wt: 221.14

Inv. Status: In Stock

N-Nitroso Sitagliptin Impurity 2

Cat. No: CL-STG-NO-02

CAS No: NA

Mol. F: C6H8F3N5O2

Mol. Wt: 239.16

Inv. Status: Custom Synthesis

N-Nitroso Sitagliptin Impurity 3

Cat. No: CL-STG-NO-03

CAS No: NA

Mol. F: C10H9F6N7O3

Mol. Wt: 389.22

Inv. Status: Custom Synthesis

N-Nitroso Sitagliptin Impurity 4

Cat. No: CL-STG-NO-04

CAS No: NA

Mol. F: C6H8F3N5O2

Mol. Wt: 239.16

Inv. Status: Custom Synthesis

N-Nitroso Sitagliptin Impurity A

Cat. No: CL-STG-NO-05

CAS No: NA

Mol. F: C20H18F6N6O6

Mol. Wt: 552.4

Inv. Status: Custom Synthesis

N-Nitroso Sitagliptin Impurity 5

Cat. No: CL-STG-NO-06

CAS No: NA

Mol. F: C6H8F3N5O2

Mol. Wt: 239.2

Inv. Status: Custom Synthesis

N-Nitroso Sitagliptin Impurity 6

Cat. No: CL-STG-NO-07

CAS No: NA

Mol. F: C6H7F3N6O3

Mol. Wt: 268.2

Inv. Status: Custom Synthesis

N-Nitroso Sitagliptin Impurity 7

Cat. No: CL-STG-NO-08

CAS No: NA

Mol. F: C32H24F12N10O3

Mol. Wt: 824.59

Inv. Status: Custom Synthesis

N-Nitroso Sitagliptin Impurity 8

Cat. No: CL-STG-NO-09

CAS No: NA

Mol. F: C10H8F6N8O4

Mol. Wt: 418.22

Inv. Status: Custom Synthesis

N-Nitroso Sitagliptin Impurity 9

Cat. No: CL-STG-NO-10

CAS No: NA

Mol. F: C28H39F3N4O5

Mol. Wt: 568.64

Inv. Status: Custom Synthesis

N-Nitroso Sitagliptin Impurity 10

Cat. No: CL-STG-NO-11

CAS No: NA

Mol. F: C28H39F3N4O5

Mol. Wt: 568.64

Inv. Status: Custom Synthesis